EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues
Novavax, Inc. (NVAX) EBITDA Margin data is not available.
| Income Statement Financials | |
$68.30M |
|
$-31.38M |
|
$23.49M |
|
$44.81M |
|
$99.58M |
|
$-31.28M |
|
$1.63M |
|
$-29.65M |
|
$-29.65M |
|
$-31.38M |
|
$-31.38M |
|
$-31.38M |
|
$-31.38M |
|
$-31.28M |
|
$-28.23M |
|
164.92M |
|
164.92M |
|
$-0.19 |
|
$-0.19 |
|
| Balance Sheet Financials | |
$707.96M |
|
$36.28M |
|
$180.05M |
|
$888.00M |
|
$329.85M |
|
$293.61M |
|
$775.01M |
|
$1.10B |
|
$-216.85M |
|
$-328.93M |
|
$-216.85M |
|
164.99M |
|
| Cash Flow Statement Financials | |
$-199.47M |
|
$134.32M |
|
$36.88M |
|
$256.05M |
|
$227.06M |
|
$-29.00M |
|
$23.77M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.15 |
|
-- |
|
-- |
|
3.83 |
|
-1.36 |
|
65.61% |
|
-45.80% |
|
-45.80% |
|
|
EBITDA Margin |
-- |
-43.42% |
|
-45.94% |
|
$-202.35M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
1.27 |
|
1.39 |
|
64.78 |
|
14.47% |
|
9.54% |
|
-3.53% |
|
-40.88% |
|
$-1.31 |
|
$-1.23 |
|
$-1.21 |
|